Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19hcq.org COVID-19 treatment researchHCQHCQ (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

Pharmacotherapy for Covid-19 infection in the countries of the Cooperation Council for the Arab States

Boretti, A., Journal of Taibah University Medical Sciences, doi:10.1016/j.jtumed.2021.08.005
Sep 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
HCQ for COVID-19
1st treatment shown to reduce risk in March 2020, now with p < 0.00000000001 from 419 studies, recognized in 46 countries.
No treatment is 100% effective. Protocols combine treatments.
5,300+ studies for 115 treatments. c19hcq.org
Review of country COVID-19 treatment guidelines suggesting that early use of antivirals is a determing factor in the countries with lower mortality.
Reviews covering hydroxychloroquine for COVID-19 include1-27.
Boretti et al., 4 Sep 2021, peer-reviewed, 1 author.
This PaperHCQAll
Pharmacotherapy for COVID-19 infection in the countries of the Cooperation Council for the Arab States
Ph.D Alberto Boretti
Journal of Taibah University Medical Sciences, doi:10.1016/j.jtumed.2021.08.005
To the
Conflict of interest The author has no conflict of interest to declare. Ethical approval The authors confirm that this letter has been prepared in accordance with COPE roles and regulations. Given the nature of the letter, no IRB review was required.
References
Boretti, Analysis of the performances of the covid-19 therapeutic approaches in the United Arab Emirates, Signa Vitae
Hosany, Ganesan, Memari, Mazrouei, Ahamed et al., Response to COVID-19 pandemic in the UAE: a public health perspective, J Glob Health
Ourworldindata, Coronavirus data explorer
DOI record: { "DOI": "10.1016/j.jtumed.2021.08.005", "ISSN": [ "1658-3612" ], "URL": "http://dx.doi.org/10.1016/j.jtumed.2021.08.005", "alternative-id": [ "S165836122100158X" ], "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Pharmacotherapy for COVID-19 infection in the countries of the Cooperation Council for the Arab States" }, { "label": "Journal Title", "name": "journaltitle", "value": "Journal of Taibah University Medical Sciences" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.jtumed.2021.08.005" }, { "label": "Content Type", "name": "content_type", "value": "simple-article" }, { "label": "Copyright", "name": "copyright", "value": "© 2021 The Author. Production and hosting by Elsevier Ltd on behalf of Taibah University." } ], "author": [ { "affiliation": [], "family": "Boretti", "given": "Alberto", "sequence": "first" } ], "container-title": "Journal of Taibah University Medical Sciences", "container-title-short": "Journal of Taibah University Medical Sciences", "content-domain": { "crossmark-restriction": true, "domain": [ "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2021, 9, 4 ] ], "date-time": "2021-09-04T11:44:41Z", "timestamp": 1630755881000 }, "deposited": { "date-parts": [ [ 2021, 9, 29 ] ], "date-time": "2021-09-29T23:45:49Z", "timestamp": 1632959149000 }, "indexed": { "date-parts": [ [ 2023, 11, 8 ] ], "date-time": "2023-11-08T13:32:45Z", "timestamp": 1699450365663 }, "is-referenced-by-count": 2, "issue": "5", "issued": { "date-parts": [ [ 2021, 10 ] ] }, "journal-issue": { "issue": "5", "published-print": { "date-parts": [ [ 2021, 10 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 10, 1 ] ], "date-time": "2021-10-01T00:00:00Z", "timestamp": 1633046400000 } }, { "URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 8, 26 ] ], "date-time": "2021-08-26T00:00:00Z", "timestamp": 1629936000000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S165836122100158X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S165836122100158X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "794-797", "prefix": "10.1016", "published": { "date-parts": [ [ 2021, 10 ] ] }, "published-print": { "date-parts": [ [ 2021, 10 ] ] }, "publisher": "Elsevier BV", "reference": [ { "key": "10.1016/j.jtumed.2021.08.005_bib1", "series-title": "Coronavirus data explorer", "year": "2020" }, { "key": "10.1016/j.jtumed.2021.08.005_bib2", "series-title": "Solidarity trial reports interim results", "year": "2020" }, { "key": "10.1016/j.jtumed.2021.08.005_bib3", "series-title": "Saudi MoH protocol for patients suspected of/confirmed with COVID-19 supportive care and antiviral treatment of suspected or confirmed COVID-19 infection, Kingdom of Saudi Arabia Ministry of Health 22nd January 2021", "year": "2021" }, { "key": "10.1016/j.jtumed.2021.08.005_bib4", "series-title": "National guidelines for clinical management and treatment of COVID-19 1st June 2020", "year": "2020" }, { "key": "10.1016/j.jtumed.2021.08.005_bib5", "series-title": "COVID-19 guideline for healthcare professionals Abu Dhabi December 20th, 2020", "year": "2020" }, { "key": "10.1016/j.jtumed.2021.08.005_bib6", "series-title": "Database of all HCQ COVID-19 studies, c19study.com", "year": "2021" }, { "article-title": "Analysis of the performances of the covid-19 therapeutic approaches in the United Arab Emirates", "author": "Boretti", "first-page": "256", "issue": "3", "journal-title": "Signa Vitae", "key": "10.1016/j.jtumed.2021.08.005_bib7", "volume": "17", "year": "2021" }, { "article-title": "Response to COVID-19 pandemic in the UAE: a public health perspective", "author": "Al Hosany", "first-page": "3050", "journal-title": "J Glob Health", "key": "10.1016/j.jtumed.2021.08.005_bib8", "volume": "11", "year": "2021" } ], "reference-count": 8, "references-count": 8, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S165836122100158X" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Pharmacotherapy for COVID-19 infection in the countries of the Cooperation Council for the Arab States", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "16" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit